Stoke Therapeutics (STOK) Tax Provisions (2025)

Stoke Therapeutics' (STOK) quarterly Tax Provisions came in at -$1.3 million in Q3 2025, down 200.0% quarter-over-quarter from $1.3 million in Q1 2025.

Stoke Therapeutics (STOK) Tax Provisions (2025) Analysis & Trends

Stoke Therapeutics' Tax Provisions history runs 1 years deep, the most recent figure standing at -$1.3 million for Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 125,146.46
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 31.86 Mn
4 NuCana 279.75 Bn 279.75 Bn - 188,883.60
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 221.50 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 179.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Stoke Therapeutics 1.87 Bn 1.53 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -1.28 Mn
Mar 31, 2025 1.28 Mn